Skip to main content

Table 2 Baseline characteristics and outcomes

From: Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study

 

Site of first primary cancer

 

All cancer* (C00-C97)

Lung (C33-34)

Colorectal (C18-20)

Female breast (C50)

Prostate (C61)

Head & neck (C00-14, C30-32)

Stomach (C16)

Bladder (C67)

Oesophagus (C15)

Melanoma (C43)

Ovarian (C56)

 

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

Total

56564

 

10764

(19.0)

7225

(12.8)

8386

(14.8)

5269

(9.3)

2398

(4.2)

2079

(3.7)

1832

(3.2)

1780

(3.1)

1696

(3.0)

1325

(2.3)

Men

27561

(48.7)

5894

(54.8)

3834

(53.1)

  

5269

(100.0)

1697

(70.8)

1262

(60.7)

1233

(67.3)

1094

(61.5)

736

(43.4)

  

Mean age (SD) years

66.6

(13.8)

70.0

(10.2)

69.9

(11.7)

62.0

(14.3)

71.6

(9.1)

63.3

(12.2)

70.6

(11.7)

71.8

(10.5)

69.8

(11.6)

55.5

(18.0)

63.8

(14.7)

Age (years)

                      

15– < 50

6386

(11.3)

345

(3.2)

388

(5.4)

1660

(19.8)

42

(0.8)

277

(11.6)

113

(5.4)

46

(2.5)

85

(4.8)

646

(38.1)

219

(16.5)

50– < 70

23787

(42.1)

4513

(41.9)

2868

(39.7)

4089

(48.8)

2098

(39.8)

1385

(57.8)

763

(36.7)

658

(35.9)

735

(41.3)

619

(36.5)

599

(45.2)

70+

26391

(46.7)

5906

(54.9)

3969

(54.9)

2637

(31.4)

3129

(59.4)

736

(30.7)

1203

(57.9)

1128

(61.6)

960

(53.9)

431

(25.4)

507

(38.3)

Number of patients with second primary cancer*

2137

(3.8)

119

(1.1)

324

(4.5)

363

(4.3)

342

(6.5)

204

(8.5)

46

(2.2)

140

(7.6)

26

(1.5)

102

(6.0)

20

(1.5)

Second or later cancer

                      

Lung (C33-34)

507

(23.7)

24

(20.2)

65

(20.1)

67

(18.5)

91

(26.6)

88

(43.1)

13

(28.3)

50

(35.7)

6

(23.1)

14

(13.7)

3

(15.0)

Colorectal (C18-20)

315

(14.7)

11

(9.2)

56

(17.3)

52

(14.3)

80

(23.4)

17

(8.3)

8

(17.4)

15

(10.7)

6

(23.1)

9

(8.8)

1

(5.0)

Female Breast (C50)

237

(11.1)

14

(11.8)

25

(7.7)

98

(27.0)

 

(0.0)

5

(2.5)

6

(13.0)

3

(2.1)

0

(0.0)

15

(14.7)

6

(30.0)

Prostate (C61)

162

(7.6)

11

(9.2)

45

(13.9)

 

(0.0)

3

(0.9)

11

(5.4)

3

(6.5)

39

(27.9)

1

(3.8)

8

(7.8)

0

(0.0)

Head & neck (C00-C14, C30-C32)

107

(5.0)

15

(12.6)

12

(3.7)

11

(3.0)

15

(4.4)

32

(15.7)

2

(4.3)

2

(1.4)

5

(19.2)

2

(2.0)

0

(0.0)

Stomach (C16)

83

(3.9)

6

(5.0)

16

(4.9)

7

(1.9)

22

(6.4)

6

(2.9)

3

(6.5)

7

(5.0)

0

(0.0)

0

(0.0)

0

(0.0)

Bladder (C67)

78

(3.6)

8

(6.7)

9

(2.8)

6

(1.7)

20

(5.8)

9

(4.4)

2

(4.3)

1

(0.7)

2

(7.7)

3

(2.9)

0

(0.0)

Oesophagus (C15)

73

(3.4)

4

(3.4)

7

(2.2)

9

(2.5)

10

(2.9)

18

(8.8)

1

(2.2)

3

(2.1)

1

(3.8)

3

(2.9)

0

(0.0)

Melanoma (C43)

84

(3.9)

2

(1.7)

8

(2.5)

17

(4.7)

14

(4.1)

0

(0.0)

1

(2.2)

2

(1.4)

0

(0.0)

28

(27.5)

2

(10.0)

Pancreas (C25)

49

(2.3)

1

(0.8)

12

(3.7)

10

(2.8)

7

(2.0)

1

(0.5)

1

(2.2)

5

(3.6)

0

(0.0)

4

(3.9)

0

(0.0)

Ovarian (C56)

34

(1.6)

0

(0.0)

3

(0.9)

19

(5.2)

 

(0.0)

0

(0.0)

0

(0.0)

0

(0.0)

0

(0.0)

1

(1.0)

1

(5.0)

Kidney (C64)

52

(2.4)

6

(5.0)

7

(2.2)

7

(1.9)

11

(3.2)

4

(2.0)

1

(2.2)

0

(0.0)

1

(3.8)

2

(2.0)

0

(0.0)

Corpus uteri (C54)

42

(2.0)

1

(0.8)

9

(2.8)

20

(5.5)

 

(0.0)

2

(1.0)

1

(2.2)

0

(0.0)

1

(3.8)

0

(0.0)

3

(15.0)

All other cancers*

314

(13.9)

16

(12.9)

50

(14.7)

40

(10.6)

69

(19.2)

11

(4.8)

4

(8.5)

13

(8.8)

3

(11.1)

13

(11.9)

4

(19.0)

Number of deaths

34648

(61.3)

10130

(94.1)

4283

(59.3)

2429

(29.0)

2169

(41.2)

1262

(52.6)

1835

(88.3)

1157

(63.2)

1629

(91.5)

373

(22.0)

879

(66.3)

  1. *excluding non-melanoma skin cancer.